Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer

PURPOSE: A phase I clinical trial and molecular correlative studies were performed to evaluate preclinical evidence for combinatorial activity of proteasome inhibitor bortezomib, epidermal growth factor receptor (EGFR) inhibitor cetuximab, and radiation therapy. EXPERIMENTAL DESIGN: Patients with ra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Argiris, Athanassios, Duffy, Austin G., Kummar, Shivaani, Simone, Nicole L., Arai, Yoshio, Kim, Seungwon W., Rudy, Susan. F., Kannabiran, Vishnu. R., Yang, Xinping, Jang, Minyoung, Chen, Zhong, Suksta, Nanette, Cooley-Zgela, Theresa, Ramanand, Susmita G., Ahsan, Aarif, Nyati, Mukesh. K., Wright, John J., Van Waes, Carter
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3368806/
https://ncbi.nlm.nih.gov/pubmed/21750205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados